In several models of aging, microglia become more inflammatory and reactive to immune challenges. For example, peripheral LPS injection causes exaggerated microglial activation associated with prolonged sickness and depressive-like behavior in aged BALB/c mice. Therefore, the purpose of this study was to determine the extent to which age-related amplified microglial activation was associated with reduced sensitivity to the anti-inflammatory and M2 promoting cytokines interleukin (IL)-10 and IL-4. In initial studies with adult mice, LPS induced a time-dependent increase in M1 and M2 mRNA profiles in microglia. Furthermore, peripheral LPS injection markedly increased surface expression of IL-4 receptor-alpha (IL-4Ra), but not IL-10 receptor-1 (IL-10R1) on microglia. In BV-2 cells, IL-4, but not IL-10, re-directed LPS-activated microglia towards an M2 phenotype. Based on these findings, comparisons of M1 and M2 activation profiles, induction of IL-4Ra, and sensitivity to IL-4 were determined in microglia from adult (3-4 mo) and aged (18-22 mo) mice. In aged microglia, LPS promoted an exaggerated and prolonged M1 and M2 profile compared to adults. Moreover, IL-4Ra protein was not increased on aged microglia following LPS injection. To determine the consequence of impaired IL-4Ra upregulation, adult and aged mice were injected with LPS and activated microglia were then isolated and treated ex vivo with IL-4. While ex vivo IL-4 induced an M2 profile in activated microglia from adult mice, activated microglia from aged mice retained a prominent M1 profile. These data indicate that activated microglia from aged mice are less sensitive to the anti-inflammatory and M2-promoting effects of IL-4.
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Introduction
Within the central nervous system (CNS) microglia are responsible for the induction of an innate immune response by receiving and propagating inflammatory signals (Nguyen et al., 2002) . Even in the absence of inflammatory stimuli, microglia are actively surveying their local microenvironment (Nimmerjahn et al., 2005) . Once activated by an immune stimulus, microglia perform several macrophage-like functions including phagocytosis, inflammatory and anti-inflammatory cytokine production, and antigen presentation (Garden and Moller, 2006) . This classical activation (M1) profile is transient with microglia returning to a surveying state as the immune stimulus is resolved. Key to this transition is regulation by several anti-inflammatory mediators (Biber et al., 2007) including neuronal factors, hormones, and cytokines that attenuate microglial activation and promote anti-inflammatory or repair (M2) profiles in microglia (Mantovani et al., 2004; Mosser and Edwards, 2008) .
In rodent models of normal and non-neurodegenerative aging, there is an increase in ''primed or reactive'' microglia that have increased expression of a number of M1 and inflammatory markers including CD86 (Downer et al., 2010 ), CD68 (Wong et al., 2005 , MHC II (Frank et al., 2006; Godbout et al., 2005b; Henry et al., 2009) , and toll-like receptors (Letiembre et al., 2007) . A consequence of a more inflammatory microglial profile is an exaggerated inflammatory response following peripheral immune activation (Godbout et al., 2005b; Perry et al., 2003) . In support of this notion, central (Abraham et al., 2008; Huang et al., 2008) or peripheral innate immune challenges (Chen et al., 2008; Godbout et al., 2005a; Henry et al., 2009; Wynne et al., 2010) lead to amplified and prolonged neuroinflammation (oxidative stress and cytokines) mediated, in part, by a hyperactive MHC II + microglial population (Henry et al., 2009 ). An exaggerated M1 microglial response in aged mice is relevant because it is coupled with a myriad of complications including cognitive impairment (Barrientos et al., 2006; 2009; Chen et al., 2008) , exaggerated and prolonged sickness behavior (Abraham
